Your session is about to expire
← Back to Search
Celecoxib for Major Depressive Disorder
Study Summary
This trial will test whether the anti-inflammatory drug celecoxib can help reduce symptoms of major depressive disorder by reducing neuroinflammation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2009 Phase 2 trial • 203 Patients • NCT00964431Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is there an opportunity for me to participate in this research project?
"With the goal of including 42 participants in total, this medical trial seeks individuals who are between 18 and 65 years old, possess a MADRS score of 29 or higher and have an existing diagnosis of neuroinflammation."
What are the normal indications for administering Celecoxib 400 mg?
"Celecoxib 400 mg is a proven remedy for pain, as well as primary dysmenorrhoea, rheumatoid arthritis and ankylosing spondylitis."
How many participants are being observed for this research experiment?
"Affirmative. On clinicaltrials.gov, the listing for this study states that recruitment is currently underway. Originally uploaded on August 1st 2018 and most recently updated October 24th 2022, 42 patients must be enrolled from a single locale."
What safety risks are associated with a dosage of Celecoxib 400 mg?
"The safety of Celecoxib 400 mg has been validated by Phase 4 trials, and as such receives a score of 3 on our scale."
Does this research trial accept participants who are over 55 years old?
"Patients must meet two age criteria in order to be considered for the clinical trial: they should not be younger than 18 years old, nor older than 65."
Is participation in this clinical trial still available?
"Affirmative, clinicaltrials.gov verifies that this trial is recruiting participants as of now. Initially posted on August 1st 2018, the study was last amended on October 24th 2022 and still requires 42 volunteers from a single medical centre to complete it."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger